Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety

被引：0
|
作者：
Yue Ma
Ying-Chun Xu
Lei Tang
Zan Zhang
Jian Wang
Hong-Xia Wang
机构：
[1] Shanghai Jiaotong University School of Medicine,Department of Oncology, Shanghai Renji Hospital
[2] Shanghai Jiaotong University School of Medicine,Department of Surgery, Shanghai Renji Hospital
来源：
Experimental Hematology & Oncology | / 1卷 / 1期
关键词：
Cytokine-induced killer cells; Hepatocellular carcinoma; Clinical trial; Meta-analysis; Therapy;
D O I：
10.1186/2162-3619-1-11
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Improving clinical manufacturing of cytokine-induced killer (CIK) cells
    Bremm, Melanie
    Rettinger, Eva
    Cappel, Claudia
    Katzki, Verena
    Erben, Stephanie
    Betz, Sibille
    Quaiser, Andrea
    Bonig, Halvard
    Schmidt, Michael
    Pfeffermann, Lisa-Marie
    Klingebiel, Thomas
    Bader, Peter
    Huenecke, Sabine
    BONE MARROW TRANSPLANTATION, 2019, 54 : 194 - 194
  • [22] Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis
    Yu, Ruili
    Yang, Bo
    Chi, Xiaohua
    Cai, Lili
    Liu, Cui
    Yang, Lei
    Wang, Xueyan
    He, Peifeng
    Lu, Xuechun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 851 - 864
  • [23] Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
    Lee, Joon Hyeok
    Lee, Jeong-Hoon
    Lim, Young-Suk
    Yeon, Jong Eun
    Song, Tae-Jin
    Yu, Su Jong
    Gwak, Geum-Youn
    Kim, Kang Mo
    Kim, Yoon Jun
    Lee, Jae Won
    Yoon, Jung-Hwan
    GASTROENTEROLOGY, 2015, 148 (07) : 1383 - +
  • [24] Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome
    Ma, L.
    Wang, Y.
    Bo, J.
    Han, W.
    Wang, Y.
    Zhang, L.
    Wu, X.
    Yu, S.
    Liu, R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 184 (01): : 83 - 89
  • [25] Efficacy of RetroNectin-Activated Cytokine-Induced Killer Cell Therapy in Metastatic Brain Tumor Patients
    Li, Wei
    Wang, Yaomei
    Zhao, Lingdi
    Xu, Linping
    Zhang, Yong
    Mai, Ling
    Gao, Quanli
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (04) : 160 - 165
  • [26] Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma
    Han, Myung-Hoon
    Kim, Jae Min
    Cheong, Jin Hwan
    Ryu, Je Il
    Won, Yu Deok
    Nam, Gun He
    Kim, Choong Hyun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] The role of cytokine-induced killer (CIK) cells therapy in modulating tregs in patients with non-small cell lung cancer
    Yu, B.
    Wang, J.
    He, C.
    Wang, W.
    Tang, J.
    Zheng, R.
    Zhou, C.
    Zhang, H.
    Fu, Z.
    Li, Q.
    Xu, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 401 - 402
  • [28] Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: Current strategies and future challenges
    Li, Celine Man Ying
    Li, Runhao
    Drew, Paul
    Price, Timothy
    Smith, Eric
    Maddern, Guy J.
    Tomita, Yoko
    Fenix, Kevin
    CANCER TREATMENT REVIEWS, 2024, 122
  • [29] Analysis of the efficacy of cytokine-induced killer cell therapy in adjuvant treatment of colorectal cancer
    Guo, R.
    Shi, G.
    Zhang, G.
    Zhang, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S419 - S419
  • [30] THE ROLE OF CYTOKINE-INDUCED KILLER (CIK) CELLS THERAPY IN MODULATING TREGS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Yu, Baodan
    Wang, Wei
    He, Chen
    Wang, Junli
    Xu, Jun
    RESPIROLOGY, 2013, 18 : 22 - 22
12345